IGF2BP3 and acute myeloid leukemia: First, we investigated the effects of knocking down IGF2BP3 by generating two shRNA-expressing stable human AML cell lines, HL-60 and KG-1, which displayed relatively high IGF2BP3 expression among all tested AML cell lines.